SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001843575-22-000003
Filing Date
2022-08-09
Accepted
2022-08-09 21:11:15
Documents
1
Period of Report
2022-08-05

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 9222
  Complete submission text file 0001843575-22-000003.txt   10673
Mailing Address 1800 KRAFT DRIVE, SUITE 216 BLACKSBURG VA 24060
Business Address 1800 KRAFT DRIVE, SUITE 216 BLACKSBURG VA 24060 540-818-2844
Landos Biopharma, Inc. (Issuer) CIK: 0001785345 (see all company filings)

IRS No.: 815085535 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1800 KRAFT DRIVE SUITE 100 BLACKSBURG VA 24060
Business Address
Bassaganya-Riera Josep (Reporting) CIK: 0001843575 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39971 | Film No.: 221150162